Search for a trial

Multi-center, double-blind, randomized, placebo-controlled, parallel-group
study to evaluate the efficacy and safety of self-administered
subcutaneous selatogrel for prevention of all-cause death and treatment of
acute myocardial infarction in subjects with a recent history of acute
myocardial infarction

This study has been transitioned to CTIS with ID 2023-505438-85-00 check the CTIS register for the current data. The primary objective of the study is to assess the clinical efficacy of selatogrel when self-administered upon occurrence of…